Formulation optimization of serratiopeptidase-loaded PLGA microspheres using selected variables

PDA Journal of Pharmaceutical Science and Technology

Volumn 63, Issue 2, 2009, Pages 103-112

  Singh, Deependra ^a   Dixit, V K ^b   Saraf, Swarnlata ^a   Saraf, S ^a  

^a PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

Biodegradable; Factorial design; Microspheres; Proteolytic activity; Serratiopeptidase; Wound healing

Indexed keywords

MICROSPHERE; POLYGLACTIN; SERRATIOPEPTIDASE; LACTIC ACID; PEPTIDE HYDROLASE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED DRUG RELEASE; DRUG DIFFUSION; DRUG FORMULATION; IN VITRO STUDY; MICROENCAPSULATION; PARTICLE SIZE; PROTEIN DEGRADATION; RESPONSE SURFACE METHOD; SUSTAINED DRUG RELEASE; CHEMISTRY; DELAYED RELEASE FORMULATION;

CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; LACTIC ACID; MICROSPHERES; PARTICLE SIZE; PEPTIDE HYDROLASES; POLYGLYCOLIC ACID;

EID: 68349106904     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hunt, T. K.; Hopf, H.; Hussain, Z. Physiology of wound healing. Adv. Skin Wound Care 2000, 13 (2 Suppl.), 6-11.
2. Burke, J. F. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961, 50 (July), 161-168.
3. Yaakobi, T.; Roth, D.; Chen, Y.; Freeman, A. Streaming of proteolytic enzyme solutions for wound debridement: a feasibility study. Wounds 2004, 16 (6), 201-205. (Pubitemid 38901160)
4. Jenning, V.; Schafer-Korting, M.; Gohla, S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J. Controlled Release 2000, 66 (2-3), 115-126.
5. Kee, W. H.; Tan, S. L.; Lee, V.; Salmon, Y. M. The treatment of breast engorgement with Serrapeptase (Danzen): a randomized double-blind controlled trial. Singapore Med. J. 1989, 30 (1), 48-54.
6. Majima, Y.; Hirata, K.; Takeuchi, K.; Hattori, M.; Sakakura, Y. Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus. Am. Rev. Respir. Dis. 1990, 141 (1), 79-83.
7. Rawat, M.; Singh, D.; Saraf, S.; Saraf, S. Nanocarriers: promising vehicle for bioactive drugs. Biol. Pharm. Bull. 2006, 29 (9), 1790-1798.
8. Gombotz, W. R.; Pettit, D. K. Biodegradable polymers for protein and peptide drug delivery. Bioconjug. Chem. 1995, 6 (4), 332-351.
9. Schwendeman, S. P.; Cardamone, M.; Brandon, M. R.; Klibanov, A.; Langer, R. Stability of Proteins and Their Delivery from Biodegradable Polymer Microparticles. In Microparticulate Systems for the Delivery of Proteins and Vaccines; Marcel Dekker: New York, 1996; pp 1-49.
10. Rössler, B.; Kreuter, J.; Ross, G. Effect of collagen microparticles on the stability of retinol and its adsorption into hairless mouse skin in vitro. Pharmazie 1994, 49 (2-3), 175-179. (Pubitemid 24093107)
11. Brosse, C.; Soutif, J. C.; Bross, J. C. Preparation of microcapsules for skin allergy testing by solvent evaporation process. J. Microencapsul. 2000, 17 (1), 111-116.
12. Ogawa, Y.; Yamamoto, M.; Okada, H.; Yashiki, T.; Shimamoto, T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem Pharm Bull. (Tokyo) 1988, 36 (3), 1095-1103.
13. Brannon-Peppas, L.; Vert, M. Polylactic and Polyglycolic Acid Acids as Drug Carriers. In Handbook of Pharmaceutical Controlled Release Technology; Wise, D. L., Ed.; Marcel Dekker: New York, 2000; pp 99-130.
14. Rawat, M.; Singh, D.; Saraf, S.; Saraf, S. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme. Drug Dev. Ind. Pharm. 2008, 34 (2), 181-188.
15. Rawat, M.; Saraf, S.; Saraf, S. Influence of selected formulation variables on the preparation of enzyme entrapped Eudragit S100 microspheres. AAPS PharmSciTech 2007, 8 (4), E116.
16. nd ed.; Marcel Dekker: New York, 1990.
17. Bloomfield, M. S.; Butler, W. C. Robustness testing, using experimental design, of a flow-through dissolution method for a product where actives have markedly differing solubility properties. Int. J. Pharm. 2000, 206 (1-2), 55-61.
18. Cohen, S.; Yoshiaka, T.; Lucarelli, M.; Hwang, L. H.; Langer, R. Controlled delivery system for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 1991, 8 (6), 713-720.
19. Jain, D.; Panda, A. K.; Majumdar, D. K. Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech 2005, 6 (1), E100-E107.
20. Rosa, G. D.; Iommelli, R.; La Rotonda, M. I.; Miro, A.; Quaglia, F. Influence of different nonionic surfactants on the properties of PLGA insulin-loaded microspheres. J. Controlled Release 2000, 69, 283-295.
21. Lee, J. H.; Park, T. G.; Lee, Y. B.; Shin, S. C.; Choi, H. K. Effect of adding non-volatile oil as a core material for the floating microspheres prepared by emulsion solvent diffusion method. J. Microencapsul. 2001, 18 (1), 65-75.
22. Dashora, K.; Saraf, S.; Saraf, S. Effect of processing variables on micro particulate system of aceclofenac. Pak. J. Pharm. Sci. 2006, 19 (1), 6-10.
23. Saudagar, R. B.; Rawat, M.; Singh, D.; Saraf, S.; Saraf, S. Development and validation of derivative spectrophotometric method for determination of serratiopeptidase in pharmaceutical formulation. Oriental J. Chem. 2008, 23, 113-114.
24. Committee on Institute of Medicine. Food and Chemical Codex, 4th ed. Washington, DC; National Academic Press, 2003.
25. Uchida, T.; Yoshida, K.; Ninomiya, A.; Goto, S. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin. Chem. Pharm. Bull. (Tokyo) 1995, 43 (9), 1569-1573.
26. Jalil, R.; Nixon, J. R. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J. Microencapsul. 1990, 7 (3), 297-325.
27. Salamone, P. R.; Wodzinski, R. J. Production, purification and characterization of a 50-kDa extracellular metalloprotease from Serratia marcescens. Appl. Microbiol. Biotechnol. 1997, 48 (3), 317-324.
28. Mendenhall, W.; Sincich, T. Multiple Regression: A Second Course in Business Statistics: Regression Analysis, 3rd ed.; Dellen Publishing: CA, 1989.
29. Martinez-Sancho, C.; Herrero-Vanrell, R.; Negro, S. Optimisation of aciclovir poly(D,L-lactide-coglycolide) microspheres for intravitreal administration using a factorial design study. Int. J. Pharm. 2004, 273 (1-2), 45-56.
30. Cheu, S. J.; Chen, R. R.; Chen, P. F.; Lin, W. J. In vitro modified release of acyclovir from ethyl cellulose microspheres. J. Microencapsul. 2001, 18 (5), 559-(2001).
31. Lin, Y. H.; Vasavada, R. C. Studies on microencapsulation of 5-fluorouracil with poly(ortho ester) polymers. J. Microencapsul. 2000, 17 (1), 1-11.
32. Onuki, Y.; Morishita, M.; Takayama, K. Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery. J. Controlled Release 2004, 97 (1), 91-99.
33. Vyas, S. P.; Rawat, M.; Rawat, A.; Mahor, S.; Gupta, P. N. Pegylated protein encapsulated multivesicular liposomes: a novel approach for sustained release of Interferon-α. Drug Dev. Ind. Pharm. 2006, 32 (6), 699-707.
34. Tzafiriri, A. R. Mathematical modeling of diffusion-mediated release from bulk degrading matrices. J. Controlled Release 2000, 63 (1-2), 69-79.